Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	46	non-cytoplasmic
47	67	transmembrane
68	78	cytoplasmic
79	102	transmembrane
103	150	non-cytoplasmic
151	170	transmembrane
171	186	cytoplasmic
187	209	transmembrane
210	226	non-cytoplasmic
227	247	transmembrane
248	300	cytoplasmic
301	323	transmembrane
324	326	cytoplasmic
327	342	transmembrane
343	345	non-cytoplasmic
346	347	transmembrane
348	352	non-cytoplasmic
353	377	transmembrane
378	441	cytoplasmic

Input:
>HSERO_RS13105
MTAQKPPLYKSLYFQVLVAIVIGILLGHFYPSTGEAMKPLGDGFVKLIKMIIAPVIFCTV
VIGIAGMEDMKKVGKTGGLALLYFEVVSTVALIIGLLLVNFLQPGVGMNVDPASLDTKSI
AAYTAPGKMGSVTDFVLGIIPTSMVDAFAKGDVLQVLLVAVLFGFALHKFGGRGTLVFDF
IEKISHVLFSVVGAIMKVAPIGAFGAMSFTIGKYGVGSLFSLAKLMGTFYLTCLLFIFVV
LGIITRLHGFSIWKFVKYIKEELLIVLGTSSSESVLPRMLAKMENAGAKKTVVGLVIPTG
YSFNLDGTAIYLTMAAVFIAQATNTPMTFVQELTLLGVLLLTSKGAAGITGSGFIVLAAT
LSAVGHVPVAGLALILGIDRFMSEARALTNTIGNGVATLVVAKWSGELDSERLTKVLNNE
TVEDAQAPESILDRTDAKMHH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server